Algorithms for Screening and Management of Diabetic Kidney Disease

Daphne H. Knicely, M.D., Mark D. Corriere, M.D., Donna Myers, M.D.

Algorithms for Screening and Management of Diabetic Kidney Disease is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INTRODUCTION

Diabetic nephropathy (DN) of diabetic kidney disease is one of the most common microvascular complications of diabetes occurring in 20-40% of patients with diabetes.
≤ 12% of patients with type 1 diabetes have evidence of kidney disease by 7 years.[2]
25% of patients with type 2 diabetes have evidence of kidney disease by 10 years.[2]
A family history of parental hypertension is a risk factor for developing DN.[6]
Screening to identify DN and initial treatment is commonly performed by primary care providers and endocrinologists.[7]
Appropriate and timely referral of patients to a nephrologist is important to ensure high-level care.[7]

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INTRODUCTION

Diabetic nephropathy (DN) of diabetic kidney disease is one of the most common microvascular complications of diabetes occurring in 20-40% of patients with diabetes.
≤ 12% of patients with type 1 diabetes have evidence of kidney disease by 7 years.[2]
25% of patients with type 2 diabetes have evidence of kidney disease by 10 years.[2]
A family history of parental hypertension is a risk factor for developing DN.[6]
Screening to identify DN and initial treatment is commonly performed by primary care providers and endocrinologists.[7]
Appropriate and timely referral of patients to a nephrologist is important to ensure high-level care.[7]

There's more to see -- the rest of this entry is available only to subscribers.